Additionally, the incorporation of small hairpin RNA (shRNA) in therapeutic globin LVs, either for simultaneous reduction in βS transcripts [25] or for down-regulation of the BCL11A expression [26], can lead to SCD phenotype correction. Here, BCL11A is linked to Schnyder corneal dystrophy.